Bezwada Biomedical LLC is categorized under Medical Research in Hillsborough, NJ and active since 2005.
Bezwada Biomedical LLC was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Rao Bezwada, President at the company’s single location by writing to 15 Ilene Court # 1, Hillsborough, New Jersey NJ 08844 or by phoning (908) 334-1575. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bezwada Biomedical LLC |
| Contact Person: | Rao Bezwada, President |
| Address: | 15 Ilene Court # 1, Hillsborough, New Jersey 08844 |
| Phone Number: | (908) 334-1575 |
| Website Address: | bezwadabiomedical.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5419100 |
| Share This Business: |
Bezwada Biomedical LLC was started in 2005 to provide professional Medical Research under the SIC code 8733 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Rao Bezwada, President for inquiries that concern Bezwada Biomedical LLC by calling the company number (908) 334-1575, as your correspondence is most welcome. Additionally, the physical location of the single location of Bezwada Biomedical LLC can be found at the coordinates 40.48961,-74.64051 as well as the street address 15 Ilene Court # 1 in Hillsborough, New Jersey 08844.
For its online presence, you may visit Bezwada Biomedical LLC’s website at bezwadabiomedical.com and engage with its social media outlets through on Twitter and on Facebook.